Literature DB >> 9607878

Extracorporeal shock wave lithotripsy and glycosaminoglycans in urine.

P Winter1, G Schoeneich, K Ganter, S Winter, A Hesse.   

Abstract

In 50 calcium oxalate stone-forming patients, the total excretion of glycosaminoglycans (GAGs) and of four of its subgroups [chondroitin-4-sulfate (CS-A), chondroitin-6-sulfate (CS-C), dermatan sulfate (DS), and hyaluronic acid (HY)] were investigated before ESWL and on the following 5 days. The standard value was determined by reference to a group of healthy test subjects. The excretion of GAGs was significantly higher in healthy test persons than in stone-forming patients. Twenty-four hours after ESWL, GAG excretion increased significantly but returned to normal values in the course of three days. ESWL had no influence on the proportional composition of GAG subgroups CS-A, CS-C, DS and HY. The increase in GAG excretion after ESWL indicates a transient injury of renal tissue and of the mucous layer lining the urothelium, respectively. This lesion, however, can be regarded as temporary with restitutio ad integrum later.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607878     DOI: 10.1007/bf02550563

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  30 in total

1.  New method for quantitative determination of uronic acids.

Authors:  N Blumenkrantz; G Asboe-Hansen
Journal:  Anal Biochem       Date:  1973-08       Impact factor: 3.365

2.  [Glycosaminoglycan peptides from human knee joint cartilage].

Authors:  H Greiling; H W Stuhlsatz
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1969-04

3.  Bladder-surface glycosaminoglycans: an efficient mechanism of environmental adaptation.

Authors:  C L Parsons; C Stauffer; J D Schmidt
Journal:  Science       Date:  1980-05-09       Impact factor: 47.728

4.  Significance of glycosaminoglycans for the formation of calcium oxalate stones.

Authors:  A Hesse; H Wuzel; W Vahlensieck
Journal:  Am J Kidney Dis       Date:  1991-04       Impact factor: 8.860

5.  Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.

Authors:  A Conte; P Roca; C Genestar; F Grases
Journal:  Nephron       Date:  1989       Impact factor: 2.847

6.  Laser nephelometric determination of glycosaminoglycans--method and application.

Authors:  A M Gressner; R Scherer; H W Stuhlsatz
Journal:  J Clin Chem Clin Biochem       Date:  1983-07

7.  Inhibition of sodium urate crystal adherence to bladder surface by polysaccharide.

Authors:  C L Parsons; B Danielson; B Feldstrom
Journal:  J Urol       Date:  1985-09       Impact factor: 7.450

8.  Glycosaminoglycans in urolithiasis.

Authors:  A Nesse; G Garbossa; M C Romero; C E Bogado; J R Zanchetta
Journal:  Nephron       Date:  1992       Impact factor: 2.847

9.  Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.

Authors:  M T Nikkilä
Journal:  Urol Int       Date:  1989       Impact factor: 2.089

10.  The excretion of glycosaminoglycans in the urine of calcium-oxalate-stone patients and healthy persons.

Authors:  A Hesse; H Wuzel; W Vahlensieck
Journal:  Urol Int       Date:  1986       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.